(Q37926897)

25 August 2017

The association of diabetes and positive prostate biopsy in a US veteran population (English)

1 reference

25 August 2017

0 references

0 references

K A Moses

1

1 reference

25 August 2017

O A Utuama

series ordinal

2

1 reference

25 August 2017

M Goodman

series ordinal

3

1 reference

25 August 2017

M M Issa

series ordinal

4

1 reference

25 August 2017

language of work or name

1 reference

6 September 2011

1 reference

Prostate Cancer and Prostatic Diseases

25 August 2017

1 reference

25 August 2017

15

1 reference

25 August 2017

1

1 reference

25 August 2017

70-74

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2011.40

25 August 2017

0 references

cites work

Prevalence of diabetic retinopathy in the United States, 2005-2008.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Diabetes care in black and white veterans in the southeastern U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Cancer risk in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Diabetes mellitus and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Diabetes and the risk of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Association of diabetes with prostate cancer risk in the multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Diabetes mellitus and risk of prostate cancer (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

The protective effect of diabetes mellitus against prostate cancer: role of sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Standards of medical care in diabetes--2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Risk factors for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Comparison of 12-core versus 8-core prostate biopsy: multivariate analysis of large series of US veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Increased low density lipoprotein and increased likelihood of positive prostate biopsy in black americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Risk of cancer in a large cohort of U.S. veterans with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Reduced risk of prostate cancer among patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Hormonal profile of diabetic men and the potential link to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Body mass index as a predictor of prostate cancer: development versus detection on biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Hepatitis B vaccine and liver problems in U.S. children less than 6 years old, 1993 and 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Diabetes mellitus and prostate cancer risk among older men: population-based case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.40

31 March 2020

Identifiers

DOI

10.1038/PCAN.2011.40

1 reference

25 August 2017

1 reference